Potassium Current Development and its Linkage to Membrane Expansion During Growth of Cultured Embryonic Mouse Hippocampal Neurons: Sensitivity to Inhibitors of Phosphatidylinositol 3-Kinase and Other Protein Kinases (original) (raw)

ARTICLE

Journal of Neuroscience 15 August 1998, 18 (16) 6261-6278; https://doi.org/10.1523/JNEUROSCI.18-16-06261.1998

Abstract

Hippocampal pyramidal neurons express three major voltage-dependent potassium currents, _I_A,_I_D, and_I_K. During hippocampal development,_I_A, the rapidly activating and inactivating transient potassium current, is detected soon after pyramidal neurons can be morphologically identified. Appearance of_I_A in developing pyramidal neurons is dependent on contact with cocultured astroglial cells; cultured pyramidal neurons not in contact with astroglial cells have reduced membrane area and _I_A (Wu and Barish, 1994).

We have examined intracellular signaling pathways that could contribute to the regulation of _I_A development by probing developing pyramidal neurons with kinase inhibitors. We observed that exposure to LY294002 or wortmannin, inhibitors of phosphatidylinositol (PI) 3-kinase, reduced somatic cross-sectional area, neurite outgrowth, whole-cell capacitance,_I_A amplitude and density (amplitude normalized to membrane area), and immunoreactivity for Kv4.2 and/or Kv4.3 (potassium channel subunits likely to be present in the channels carrying _I_A). In contrast, exposure to ML-9 or KN-62, inhibitors of myosin light chain kinase or Ca2+–calmodulin-dependent protein kinase II (CaMKII), reduced membrane area and _I_Aamplitude but did not affect _I_A density or Kv4.2/3 immunoreactivity to the same extent as inhibitors of PI 3-kinase. Unexpectedly, exposure to bisindolymaleimide I or calphostin C, inhibitors of protein kinase C (PKC), did not affect membrane area or potassium current development.

Our data suggest that PI 3-kinases regulate both A-type potassium channel synthesis and plasmalemmal insertion of vesicles bearing these potassium channels. CaMKII appears to regulate fusion of channel-bearing vesicles with the plasmalemma and myosin light chain kinase to regulate centripetal transport of channel-bearing vesicles from the Golgi. We further suggest that astroglial cells exert their influence on pyramidal neuron development through activation of PI 3-kinases.

Hippocampal pyramidal neurons display three major voltage-dependent potassium currents (Storm, 1990),_I_A, _I_D, and_I_K. _I_A is a rapidly activating and inactivating voltage-gated potassium current that influences the subthreshold electrical behavior of neurons (Connor and Stevens, 1971a,b). It is a particularly important regulator of postsynaptic efficacy and dendritic excitability in pyramidal neurons (Hoffman et al., 1997). Physiological evidence suggests that the_Shal_-related potassium channel subunits Kv4.2 and/or Kv4.3 (Serôdio et al., 1996; Tsaur et al., 1997) are likely to be components of the dendritic potassium channels carrying_I_A in hippocampal neurons (Serôdio et al., 1994; Keros and McBain, 1997; Johns et al., 1997), and immunocytochemical evidence indicates that Kv4.2 and/or Kv4.3 protein is localized to the somatic and dendritic compartments of hippocampal pyramidal neurons (Sheng et al., 1992; Maletic-Savatic et al., 1995b;Tsaur et al., 1997; see below). Control of the insertion of these channels into dendritic membrane is thus critical for tuning the integrative properties of pyramidal neuron dendrites.

_I_A is detected early in the development of hippocampal pyramidal neurons, and _I_A amplitude increases rapidly during the late embryonic–early postnatal developmental period (Ficker and Heinemann, 1992; Spigelman et al., 1992; Wu and Barish, 1992). One factor influencing the development of_I_A in pyramidal neurons in dissociated cell culture is contact of individual neurons with cocultured astroglial cells (Wu and Barish, 1994; see also Barish, 1995). Pyramidal neurons in contact with astroglial cells have greater membrane area and a prominent _I_A; pyramidal neurons not in contact with astroglial cells have reduced membrane area and are deficient in _I_A. This _I_Adeficit is seen in both _I_A amplitude and in_I_A density (amplitude normalized to membrane area). We have suggested that glial-derived signals, transmitted by cell–cell contact or short-range diffusion, promote insertion of surface membrane enriched in A-type potassium channels. We have hypothesized, therefore, that astroglial contact is promoting two parallel processes: (1) membrane expansion and neurite outgrowth and (2) synthesis, transport, and/or insertion of A-type potassium channels into areas of expanding plasmalemma.

In the present experiments we have examined second messenger systems that may regulate _I_A development by using selective inhibitors to probe kinases implicated in receptor signaling, and/or control of membrane trafficking and exocytosis: (1) phosphatidylinositol (PI) 3-kinase, (2) myosin light chain kinase, (3) Ca2+–calmodulin-dependent protein kinase II (CaMKII), and (4) protein kinase C (PKC), as well as (5) multiple kinases (using less selective kinase inhibitors). We made measurements of membrane area, amplitudes and densities of the three voltage-gated potassium currents, and in some particularly interesting cases, the subcellular distributions of Kv4.2 and/or Kv4.3 potassium channel subunits.

Our results indicate that in developing hippocampal pyramidal neurons PI 3-kinases have a central role in regulating synthesis of the channels carrying _I_A and in regulating insertion of vesicles bearing these and other potassium channels into the expanding plasmalemma. Our data also indicate that CaMKII regulates fusion of channel-bearing vesicles with the plasmalemma, and that myosin light chain kinase influences centripetal transport of channel-bearing vesicles from the Golgi. We further suggest that PI 3-kinases may mediate the effects of astroglial cells on dendritic growth and _I_A development.

Some of these results have previously been published in abstract form (Wu and Barish, 1996).

MATERIALS AND METHODS

Dissociated cell culture. Embryonic Swiss Webster mice were removed under sterile conditions from pregnant female mice after anesthesia (by halothane inhalation) and cervical dislocation, using procedures meeting National Institutes of Health guidelines. Hippocampi were removed from fetuses and dissociated using papain (Worthington, Freehold, NJ), as described in Wu and Barish (1992). Dissociated cells were plated at ∼22,100 cells/cm2(25,000 cells per coverslip) onto poly-d-lysine-coated and laminin-coated 12 mm-diameter glass coverslips (Assistent; Carolina Biological, Burlington, NC) in a 150 μl bubble of medium (described below) supplemented to 10% total serum. After allowing 2 hr for the cells to settle, each 35 mm-diameter Petri dish containing three coverslips was flooded with 1 ml of low-serum (2% total) medium.

Low-serum medium, which facilitates growth of neurons on a sparse underlying layer of astroglial cells, consisted of MEM supplemented with 1 mm glutamine, B-27 additive (1:50; Brewer et al., 1993), 1% fetal bovine serum, and 1% horse serum, with total glucose increased to 25 mm. No antibiotics were used, and an antimitotic, ara-C (10 μm), was added after 12–48 hr to control astroglial proliferation as desired. All components of tissue culture media, including sera and B-27, were purchased from Life Technologies (Gaithersburg, MD).

Electrophysiology. Procedures for whole-cell voltage clamp of voltage-gated potassium current were standard and described in previous publications (Wu and Barish, 1992, 1994). The internal and external solutions were designed to minimize contributions of currents other than the three voltage-gated potassium currents under consideration.

Whole-cell recordings were made using an Axopatch 1B (Axon Instruments, Foster City, CA) amplifier modified for phase lag series resistance compensation and a TL-1/pClamp6 (Axon Instruments) data acquisition and analysis system. Currents were filtered in the Axopatch amplifier at 1 kHz (−3 db; 4-pole Bessel filter). Currents linear with membrane voltage (leak currents and residual capacity transients) were subtracted using a P/−4 voltage step protocol. Voltages were corrected for junction potentials between electrode and bath solutions, and series resistance was corrected at the amplifier to ∼80%. Recordings were made at room temperature (22–24°C).

The external solution was based on HBSS and contained (in mm): 140 NaCl, 5.8 KCl, 1.8 CaCl2, 1 MgCl2, 4.2 NaHCO3, 5.5 glucose, and 15 HEPES, pH 7.3. The normal internal solution contained (in mm): 59 KF, 59 KCl, 1 CaCl2, 2 MgCl2, 11 EGTA or BAPTA, and 10 HEPES, pH 7.3. External solutions contained tetrodotoxin (1 μm) to block voltage-gated sodium conductances. Reagents for physiological solutions were purchased from Sigma (St. Louis, MO).

The bath chamber (volume 0.4 ml) was continuously perfused at a rate of 0.4 ml/min using a peristaltic pump. Channel blockers and other reagents were applied using a slightly pressurized large bore (tip diameter ∼400 μm) puffer pipette. The exchange time of the solution surrounding the target cell was estimated to be 250–500 msec based on the change in tip potential of a patch pipette in the normal bath solution to a puff of 100 mm KCl.

Immunocytochemistry. At the appropriate growth stage, neurons were fixed by immersing coverslips in 4% paraformaldehyde in PBS (in mm: 137 NaCl, 2.7 KCl, and 10 Sigma catalog #410-3S phosphate buffer solution, pH 7.4) at 37°C for 1 hr, rinsed in PBS, and stored in 0.1% paraformaldehyde in PBS at 4°C until use. After rinsing stored coverslips in buffer, they were permeabilized in PBS containing 0.3% Triton X-100 for 15 min at 37°C, then rinsed again and blocked for 1 hr at room temperature with 4% blocking reagent (Boehringer Mannheim, Indianapolis, IN) plus 0.1% Triton X-100 in PBS. All remaining steps were performed at room temperature. Coverslips were incubated in primary antibody for 2 hr and washed three times for 10 min each in PBS containing 0.3% Triton X-100, and then were washed one time for 30 min in PBS. Coverslips were then incubated in biotinylated goat anti-rabbit antibody (1:1000; Vector Laboratories, Burlingame, CA) for 1 hr, washed as above, and amplified using biotin (Berghorn et al., 1994). Coverslips were first incubated in streptavidin–horseradish peroxidase (1:5000; TSA Indirect kit, Dupont NEN, Boston, MA), then in biotinyl tyramide (5 μl/ml, prepared as directed), and then in streptavidin-Cy3 (1:2500; Jackson ImmunoResearch, West Grove, PA), each for 30 min, followed by three washes for 10 min each in PBS plus 0.3% Triton X-100. They were then mounted in Vectashield (Vector Laboratories) and viewed.

Images were collected with a Zeiss 310 laser-scanning confocal microscope using 543 nm excitation and a long-pass barrier filter (Chroma, Brattleboro, VT). The fluorescence images presented here were acquired at 512 × 512 or 1024 × 1024 pixels using a 20 μm-diameter pin hole (depth of field ∼1 μm), and were taken from the lower (nearer the coverslip) portions of each neuron.

Use of the Boehringer blocking reagent in conjunction with the biotin amplification procedure aided in obtaining high resolution images with low background fluorescence.

Morphometrics. After 4 d in culture, neurons were fixed at room temperature in 4% paraformaldehyde, and a small drop of the fluorescent lipophilic dye DiI (dissolved in cod liver oil) was placed on a soma. Cells were held at 4°C overnight to allow the dye to diffuse through the membrane and then imaged on the confocal microscope (at maximum pin hole diameter). Images were exported in TIFF format to the Optimas image analysis package (Optimas Corporation, Bothell, WA). Measurements were made manually from these images by drawing a cursor across the soma or along a neurite, and length values were exported into a spreadsheet for further analysis.

Materials. Tetrodotoxin, LY294002, wortmannin, ML-9, KN-62, staurosporine, and K252a were all purchased from Calbiochem (San Diego, CA).

The polyclonal antiserum against Kv4.2/3 (Barry et al., 1995) was a gift from Drs. D. M. Barry and J. M. Nerbonne (Department of Pharmacology, Washington University School of Medicine, St. Louis, MO).

Data presentation. All data are presented as mean ± SD. Statistical comparisons were made using either Student’s_t_ test or Dunnett multiple comparisons test as appropriate (Instat; Graph Pad, San Diego, CA). Significance was assessed as_p_ < 0.05.

RESULTS

Technical considerations

All of the data presented here were taken from morphologically identified mouse hippocampal pyramidal neurons (Banker and Cowan, 1977,1979; Kriegstein and Dichter, 1983) in cultures of cells dissociated from hippocampi isolated from mouse fetuses at embryonic days 15 or 16 and grown in culture for 4–7 d. Kinase inhibitors were added 2 hr after cells were plated and were present continuously until cell-bearing coverslips were rinsed for electrophysiological recording or for immunochemistry.

Separation of three distinct voltage-gated potassium currents,_I_A, _I_D, and_I_K (Storm, 1990) followed procedures described in publications from this laboratory and others (Ficker and Heinemann, 1992; Wu and Barish, 1992). Briefly, sodium currents were blocked by adding TTX (1 μm) to all external solutions; calcium currents and calcium-dependent potassium currents were minimized by using physiological [Ca2+] in external solutions (1.8 mm), by incorporating potassium fluoride in internal solutions, and by intracellular dialysis with EGTA- or BAPTA-containing solutions. Under these conditions we have not observed any effect on potassium currents of adding Ni2+ or Cd2+ to external solutions at blocking concentrations. Neurons were held under voltage clamp at −80 mV, and maximal availability of all voltage-gated currents was achieved by imposing a 1000-msec-long conditioning hyperpolarization to −120 mV. Potassium currents were measured at a test voltage of +40 mV, at which_I_A is maximally activated._I_A was defined as the current sensitive to a conditioning 50–80-msec-long prepulse to −40 mV,_I_D as the current sensitive to 100–200 μm 4-AP, and _I_K as the TEA-sensitive current remaining after block of_I_A by the prepulse and block of_I_D by exposure to 4-AP. An example of this separation is shown in Figure 3.

Cell capacitance was also measured as described in previous publications (Wu and Barish, 1992). After establishing the initial high resistance seal and in-amplifier compensation for pipette and patch membrane capacitance, the patch was ruptured and the whole-cell condition was established. Before imposing any additional capacitance compensation, a series of 10 short (20-msec-long) depolarizations from −70 to −60 mV were delivered, and the currents were averaged. Whole-cell capacitance was evaluated by integrating the area under the capacity transient to measure Q (total charge transferred) and computed from the relation C =Q/ΔV, where C is cell capacitance and ΔV is the magnitude of the voltage step.

We believe that measurements of whole-cell capacitance and voltage-gated potassium currents and analyses of membrane insertion were all made from a somatodendritic compartment subject to reasonable voltage control and also susceptible to inhibition of membrane insertion. In cultured neurons A-type potassium channels are found on somata and apical dendrites (as assessed during single channel recording; R.-L. Wu and M. E. Barish, unpublished observations), and the cross-sectional area of this compartment, as described below, was reduced by kinase inhibitors. Cable analysis of hippocampal pyramidal neurons in situ (Johnston and Brown, 1984) indicates that even rapid synaptic events located on the apical dendrite can be well clamped. Thus, the A-type potassium channel-bearing region of cell membrane could be subjected to electrophysiological analysis, and it was also actively inserting membrane during this developmental period.

Overview

The data that follows are grouped into three sections: first, the effects of manipulating neurite outgrowth by varying the composition of the culture medium; second, the effects of inhibiting kinases implicated in receptor signaling and/or in control of exocytosis; and third, the effects of two broad spectrum kinase inhibitors.

Culture medium and neurite outgrowth

Because we had previously observed that pyramidal neurons growing in contact with astroglial cells had enhanced membrane area, we wished to separate effects of astroglial contact from those related to membrane insertion and neurite outgrowth. To do this we compared neurons grown in serum-containing and serum-free media. Neurons grown in serum-free medium are commonly observed to have greater neurite outgrowth than neurons grown in serum-containing medium (Brewer et al., 1993; Brewer, 1995), and serum-free medium also discourages proliferation of astroglial cells and their precursors (Brewer et al., 1993). For these particular experiments we used a serum-containing medium consisting of MEM supplemented only with 10% fetal calf serum (MEM–FCS) and a serum-free medium consisting of Neurobasal supplemented only with B-27 additive (Neurobasal–B-27; Brewer et al., 1993).

Images of representative pyramidal neurons grown in these two media are shown in Figure 1A. Increased neurite outgrowth in the absence of astroglial cells is evident for the Neurobasal–B-27 cultures. Neurons in the MEM–FCS cultures grew in contact with a sparse astroglial monolayer and showed fewer neurite branches.

Fig. 1.

A, Comparison of neuronal morphology after culture in serum-containing (MEM–FCS) and serum-free (Neurobasal–B-27) media. The images illustrate enhanced neurite outgrowth by neurons cultured in Neurobasal–B-27 medium. Neurons had been in culture for 5 d. B, Effects of the culture medium on potassium current development.I_A was enhanced in neurons grown in Neurobasal–B-27 medium despite their lack of astroglial contact. Numbers of cells: 10 NB–B-27 and 8 MEM–FCS. In this and subsequent figures, * denotes p < 0.05; ** denotes_p < 0.01; and *** denotes p < 0.001.

Comparison of the electrophysiological properties of these neurons (Fig. 1B) suggests that neurite outgrowth (membrane expansion) may regulate _I_A development, and this process may be downstream of contact with astroglial cells. Although membrane area (determined as whole-cell capacitance) was comparable in the two neuronal populations, _I_A amplitude (top row) and _I_A density (current amplitude normalized to cell capacitance and expressed as picoamperes per picofarad; bottom row) was increased significantly in neurons grown under serum-free conditions. This result is contrary to what would be expected if astroglial contact alone was regulating appearance of _I_A and instead suggests that, in these cultures, greater neurite outgrowth was responsible for enhanced _I_A development.

Interestingly, _I_D amplitude and density showed some reciprocity with _I_A; this reached statistical significance for _I_Ddensity. A similar relationship between _I_Aand _I_D was seen in our previous investigation of the effects of astroglial contact (Wu and Barish, 1994).

Because the growth-promoting effects of glial cells on neurons are well known (Noble et al., 1984; Fallon, 1985; Pixley et al., 1987), the results of this experiment further suggested that astroglial cells might exert their influence on _I_A development (Wu and Barish, 1994) through programs of membrane expansion and neurite outgrowth and parallel insertion of A-type potassium channels. We therefore examined intracellular signaling pathways that may be involved in these processes.

Kinases implicated in control of membrane trafficking and exocytosis

The experiments presented in this section were all performed using neurons growing on a cocultured astroglial monolayer and were designed to perturb the potassium current development promoted by astrocyte contact. The kinases targeted by the inhibitors used were as follows: PI 3-kinases by LY294002 or wortmannin; myosin light chain kinase by ML-9; CaMKII by KN-62; PKC by bisindolymaleimide, calphostin C, or K-252b; and multiple serine–threonine and tyrosine kinases by staurosporine or K-252a.

Inhibition of phosphatidylinositol 3-kinase by LY294002 and wortmannin. PI 3-kinases are a family of lipid kinases (Zvelebil et al., 1996) that catalyze phosphorylation of inositol at the D-3 position. PI 3-kinases are elements in the signaling pathways initiated by receptor tyrosine kinases (Kapeller and Cantley, 1994), and regulate, among other activities, membrane trafficking (De Camilli et al., 1996; Shepherd et al., 1996). Wortmannin and LY294002 (Vlahos et al., 1994) are structurally unrelated membrane-permeant inhibitors of PI 3-kinases.

Exposure of developing neurons to micromolar concentrations of LY294002 or wortmannin reduced both membrane area and neurite outgrowth. Shown in Figure 2, A1 and_A2_, are fluorescence images of individual neurons labeled with the membrane probe DiI. The control (Fig.2A1a,A2a) and experimental (Fig. 2A1b,c,A2b,c) fields presented illustrate the reduced somatic diameters and neurite numbers of neurons grown in the presence of LY294002 (5 μm) or wortmannin (2 μm).

Fig. 2.

A, Morphology of neurons grown in the presence of PI 3-kinase inhibitors; exposure to LY294002 (A1) or wortmannin (A2) reduced soma size and neurite outgrowth. Neurons were labeled by placing a small drop of DiI dissolved in oil on a neuron soma, as described in Materials and Methods. Shown for each inhibitor are representative examples of a control image (note that two neurons are labeled in the wortmannin control) and two experimental images. B, Measurements of neurons imaged as above. Inhibition of PI 3-kinase reduced somatic cross-sectional area (B1) and numbers of neurites (B2). The lengths of shorter neurites (i.e., lengths <30–40 μm) were minimally effected, but exposure to LY294002 affected growth of longer neurites (B3, cumulative analysis). Numbers of cells analyzed: 10 control, 17_LY294002_, and 10 wortmannin.

We quantified membrane area and neuronal morphology in terms of (1) somatic cross-sectional area, approximated as an ellipse and determined from measurements of major and minor axes, (2) numbers of first order (1o) neurites emerging from the soma or apical dendrite, and (3) the lengths of these neurites. The major effects of PI 3-kinase inhibitors were to reduce somatic size and numbers of 1o neurites, with smaller effects on the lengths of individual neurites. Somatic cross-sectional area (Fig.2B1) was reduced to ∼62% of control by LY294002 and to ∼75% of control by wortmannin. Numbers of 1o neurites per cell (Fig. 2B2) were reduced to ∼60% of control by LY294002 and to ∼47% of control by wortmannin. Surprisingly, exposure to LY294002 or wortmannin did not noticeably affect the growth of those shorter neurites that did emerge (i.e., neurites with lengths <30–40 μm), but growth of longer neurites (i.e., with lengths more than ∼50 μm) was selectively disturbed by LY294002 (Fig. 2B3).

Growth in the presence of PI 3-kinase inhibitors also affected development of voltage-gated potassium currents. Recordings shown in Figure 3, made from a control neuron and a neuron exposed to LY294002, illustrate the selective deficit in_I_A induced by the inhibitor. Shown in the_top row_ are the total potassium currents recorded during test depolarizations to +40 mV after conditioning prepulses to −120 or −40 mV (solid lines). An additional trace (dotted line) shows total current recorded after a prepulse to −120 mV in the presence of 100 μm 4-AP. The traces below show _I_A,_I_D, and _I_Kisolated as described above and illustrate the almost total loss of_I_A in the neuron exposed to LY294002._I_D and _I_K are also reduced in amplitude but not eliminated, as expected given the reduced size of neurons grown in the presence of LY294002.

Fig. 3.

Whole-cell potassium currents recorded at +40 mV from control and LY294002-treated neurons. The traces in the top row are currents recorded after conditioning prepulses to −120 and −40 mV (solid traces). Addition of 100 μm 4-AP to the bath reduced the current evoked after the prepulse to −120 mV (dotted trace). The_traces_ in the bottom rows illustrate isolation of the individual currents, as described in Results. In this example, _I_A was almost completely eliminated in the cell grown for 4 d in the presence of LY294002 (5 μm). _I_D and_I_K were smaller in the LY294002-exposed neuron, as expected from the reduced membrane area of these cells.

Comparison of electrophysiological measurements made from populations of pyramidal neurons exposed to either LY294002 or wortmannin with control neurons showed reduced total cell capacitance (an index of membrane area; Fig.4A1,2), and reduced amplitudes of _I_A,_I_D, and _I_K (Fig.5A1,2). For example, exposure to LY294002 reduced total cell capacitance to 47% of control,_I_A amplitude to 18% of control,_I_D amplitude to 51% of control, and_I_K amplitude to 37% of control. When expressed as current density (Fig.6A1,2), LY294002 reduced _I_A density to 40% of control without significantly affecting densities of _I_D or_I_K, and the same pattern was seen with wortmannin. Thus, LY294002 and wortmannin reduced_I_D and _I_K in proportion to their effects on membrane area, whereas the reduction in_I_A was greater than expected based on cell size.

Fig. 4.

Effects of growth in the presence of kinase inhibitors on whole-cell capacitance, determined as described in the Results. Shown are data for LY294002(A1), wortmannin (A2),_ML_-9 (B),KN_-62 (C), and_calphostin C (D); putative targets of these inhibitors are indicated in parentheses. Membrane area was reduced by all inhibitors except calphostin C. Data presented in Figures 4-6 are drawn from the same population of neurons, and for all three figures numbers of cells are:wortmannin, 10 control, 11 experimental;LY294002, 3 control, 5 experimental;_ML_-9, 13 control, 10 experimental;KN_-62, 8 control, 8 experimental; and_calphostin C, 14 control, 17 experimental.

Fig. 5.

Effects of growth in the presence of kinase inhibitors on amplitudes (as picoamperes measured at +40 mV) of voltage-gated potassium currents, determined as described in Results. Shown are data for LY294002(A1), wortmannin (A2),_ML_-9 (B),KN_-62 (C), and_calphostin C (D); putative targets of these inhibitors are indicated in parentheses._I_A,_I_D, and _I_Kamplitudes were all reduced by all inhibitors except calphostin C; the largest and the most significant effects were seen for inhibitors of PI 3-kinases and for _I_A and_I_K (a clear trend was seen for_I_D).

Fig. 6.

Effects of growth in the presence of kinase inhibitors on densities (as picoamperes per picofarad measured at +40 mV) of voltage-gated potassium currents, determined as described in Results. Shown are data for LY294002(A1), wortmannin (A2),_ML_-9 (B),KN_-62 (C), and_calphostin C (D); putative targets of these inhibitors are indicated in parentheses._I_A density was significantly reduced only by LY294002 and wortmannin; a trend that did not reach significance was evident for ML-9. In contrast, _I_A density was not altered by exposure to KN-62 or calphostin C, nor were densities of _I_D or_I_K affected by kinase inhibition.

The multimeric ion channels mediating _I_A(referred to here as A-type potassium channels) are likely to incorporate Kv4.2 and/or Kv4.3 protein in their pore-forming subunits (Serôdio et al., 1994; Keros and McBain, 1997; Johns et al., 1997), although they may well not be composed exclusively of Kv4.2 and/or Kv4.3 subunits. We examined the subcellular localization of A-type potassium channels under control conditions and after exposure to kinase inhibitors using an antiserum raised against a C-terminal sequence found in both Kv4.2 and Kv4.3 subunits (Barry et al., 1995). The staining pattern observed by immunofluorescence using this antiserum is referred to here as Kv4.2/3 immunoreactivity. Note that this antiserum was raised against an intracellular epitope and, therefore, that all images were acquired from permeabilized cells and, therefore, portray both internal and plasmalemmal distributions of immunoreactivity.

The images presented in Figures 7 and8 indicate that Kv4.2/3 immunoreactivity was profoundly altered by exposure to LY294002. In control neurons illustrated in Figure 7A1–A4 (shown are pairs of Nomarski DIC and confocal immunofluorescence images for two representative neurons), Kv4.2/3 immunoreactivity was dense, granular, and distributed throughout somata and dendritic processes. A void area created by the nucleus was faintly seen in these neurons. In neurons examined in other experiments this void area was often less apparent. Immunoreactivity was not evident in longer, more tubular axonal processes (Fig. 7A2,A4,arrowheads).

Fig. 7.

Distributions of Kv4.2/3 immunoreactivity in control pyramidal neurons (A) and alterations induced by growth in the presence of the kinase inhibitors LY294002 (B), ML-9 (C), and KN-62 (D). In each case, Nomarski DIC and fluorescence images are shown for two representative neurons. The_arrows_ in the fluorescence images indicate areas enlarged in Figure 8. A, Control neurons demonstrating the disperse and granular character of the Kv4.2/3 immunoreactivity. Strong Kv4.2/3 immunoreactivity is found only in somata and dendrites; tubular axonal structures (A2, A4,arrowheads) are devoid of signal. B, In neurons exposed to LY294002, the density of Kv4.2/3-immunoreactive punctata was greatly reduced, but their distribution was not significantly affected. C, In neurons exposed to ML-9, the density of Kv4.2/3-immunoreactive punctata was reduced but not to the extent seen with LY294002. In somata, punctata were found in a perinuclear array surrounding a void volume occupied by the nucleus; this was much more evident in ML-9-treated neurons than in control neurons or neurons exposed to the other inhibitors. D, In neurons exposed to KN-62, the density of Kv4.2/3-immunoreactive punctata was only slightly reduced from the control, and, as in control neurons, punctata were distributed throughout the soma and major dendrites. (Figure and legend continue)The images in Figures 7 and 8 were all acquired from two sets of sister coverslips that were grown, processed for immunochemistry, and imaged in parallel. Numbers of neurons analyzed: 17 control, 10 LY294002, 24_ML_-9, and 10_KN_-62. In general, comparisons of Kv4.2/3 immunoreactivity were performed 2–4 times for each kinase inhibitor. The luminance scale applies to all fluorescence images. Control images, in which the primary antibody was omitted, showed only background luminance (as between punctata; images not shown).

Fig. 8.

Enlarged portions of fluorescence images near the regions indicated by the arrows in Figure 7, illustrating punctate areas of Kv4.2/3 immunoreactivity. Individual punctata had diameters of 0.5–0.75 μm, because each pixel represents ∼0.2 × 0.2 μm in the image plane. In neurons exposed to_LY294002_ (B),_ML_-9 (C), or_KN_-62 (D), the maximum luminance of individual punctata was comparable to that of control neurons (A), as indicated by the luminance scale; only punctata densities and distributions appeared to be affected by the kinase inhibitors.

Processes displaying Kv4.2/3 immunoreactivity were identified as dendritic because of their tapering morphology and relatively short length (Bartlett and Banker, 1984a,b; Dotti et al., 1988) and because they express the dendritic marker MAP2 (Caceres et al., 1984; data not shown). These observations are consistent with other reports of Kv4.2/3 immunoreactivity localization to somata and dendrites of hippocampal pyramidal neurons in situ and in culture (Sheng et al., 1992; Maletic-Savatic et al., 1995b; Tsaur et al., 1997).

The size and distribution of the granular Kv4.2/3-immunoreactive punctata are shown in more detail in Figure 8A, which is taken from the region of the soma of the neuron in Figure7A3 indicated by the arrow. In this enlargement each pixel represents a square ∼0.2 × 0.2 μm; individual punctata had diameters of 0.5–0.75 μm. We assume that these punctata represent aggregates of membranous structures bearing Kv4.2/3 subunits, perhaps the tubulovesicular transport vesicles described by Nakata et al. (1998).

For neurons grown in the presence of LY294002, Kv4.2/3 immunoreactivity was dramatically reduced, as judged by the much lower density of immunoreactive punctata (Fig. 7B3,4). These punctata were distributed as in control neurons; throughout somata and dendrites but not axons and without significant accumulation in any one region. Exposure to LY294002 reduced the density of punctata, but those punctata that were evident had diameters and luminance values similar to those seen in control neurons (Fig.8B).

Inhibition of myosin light chain kinase by ML-9. Multiple members of the myosin superfamily are found in brain and may participate in aspects of membrane trafficking, including exocytosis (Mermall et al., 1998). We used the myosin light chain kinase inhibitor ML-9 (Saitoh et al., 1986).

In electrophysiological experiments, ML-9 reduced total cell capacitance in a dose-dependent manner, with reduction to 60% of control by 10 μm ML-9 (Fig. 4B). At this concentration ML-9 also reduced _I_Aamplitude to 37% of control, _I_D amplitude to 58% of control, and _I_K amplitude to 51% of control (Fig. 5B). ML-9 reduced _I_Adensity (although this did not quite reach statistical significance) without affecting the densities of the other potassium currents (Fig.6B).

Nomarski DIC images of pyramidal neurons grown in the presence of ML-9 (Fig. 7C1,2) indicated that exposure to ML-9 re- sulted in somata that were less triangular and more rounded than those of control neurons (Fig. 7A1,2). ML-9-treated neurons showed reduced density of Kv4.2/3-immunoreactive punctata (Fig.7C3,4), and these punctata showed greater accumulation in a perinuclear rind than was evident in control neurons or neurons exposed to inhibitors. Diameters of these punctata and their maximum luminance were similar to values seen in control neurons (Fig.8C).

Inhibition of Ca2+–calmodulin-dependent protein kinase II by KN-62. Multiple lines of investigation point to a role for CaMKII in control of exocytosis (see Discussion). We used the CaMKII inhibitor KN-62 (Tokumitsu et al., 1990).

Electrophysiological measurements indicated that growth in the presence of KN-62 (10 μm) reduced whole-cell capacitance to 65% of control (Fig. 4C) and reduced_I_A amplitude to 60% of control,_I_D amplitude to 60% of control, and_I_K amplitude to 52% of control (Fig.5C). However, neither _I_A,_I_D, nor _I_Kdensities were affected (Fig. 6C), despite the clear reduction in membrane area.

Images of Kv4.2/3 immunoreactivity (Fig. 7D3,4) showed a slight reduction in overall luminance as compared with control neurons (Fig. 7A3,4), but no change in its almost uniform distribution. As was true for the other inhibitors, this appeared to be attributable to a reduction in the density of Kv4.2/3-immunoreactive punctata rather than to decreases in their diameter or maximum luminance (Fig. 8D).

Inhibition of protein kinase C by calphostin C, bisindolymaleimide I, or K-252b. We explored the role of PKC in regulation of potassium current development using the inhibitors calphostin C (Kobayashi et al., 1989; Tamaoki, 1991), K-252b (Kase et al., 1987), and bisindolymaleimide I (and its inactive variant bisindolymaleimide V; Toullec et al., 1991).

Electrophysiological measurements indicated that neurons grown in the presence of bisindolymaleimide I (data not shown), calphostin C (Figs.4D, 5D, 6D), or K-252b (Fig. 10) displayed patterns of total cell capacitance and potassium current development that were similar to those of control neurons. This was in contrast to the clear effects of K-252a (see below), a structural relative of K-252b.

Broad spectrum kinase inhibitors

These experiments used two compounds, staurosporine and K-252a, that inhibit a broad spectrum of kinases (Tamaoki, 1991) and illustrate two additional points.

First, experiments with staurosporine indicated that growth in serum-free medium could mimic the effects of astroglial contact, in that membrane expansion and potassium current development showed the same sensitivity to kinase inhibition. Comparison of results obtained with 20 nm staurosporine show that neurons exposed in serum-containing medium had reduced total cell capacitance (72% of control), _I_A amplitude (33% of control), and_I_A density (41% of control), but essentially unaffected _I_D or _I_K (Fig.9A), whereas neurons exposed in serum-free medium (Neurobasal–B-27) also had reduced total cell capacitance (56% of control), _I_A amplitude (20% of control), and _I_A density (36% of control) but essentially unaffected _I_D and_I_K (Fig. 9B).

Fig. 9.

Effects of growth in the presence of staurosporine on total cell capacitance and potassium current development when neurons were grown in normal (low serum) medium (A), or serum-free Neurobasal–B-27 medium (B). Comparable results were obtained under both conditions, a result indicating that neither serum nor astroglial contact were required for kinase-sensitive control of_I_A development. A, Numbers of cells: 7 Control, 14 2 nm , and 7 20 nm .B, Numbers of cells: 4 Control, 4_2 nm_ , and 2 20 nm (neurons exposed to staurosporine in Neurobasal–B-27 medium were extremely fragile, and recordings sufficiently stable for acquisition of all data were difficult to maintain).

Second, comparison of results obtained with K-252a and K-252b confirms the general pattern of kinase sensitivities observed above. K-252a affects multiple protein kinases including PKC, cyclic nucleotide-dependent protein kinases, CaMKII, and protein tyrosine kinase, whereas K-252b is more selective for PKC (Lazarovici et al., 1996). As illustrated in Figure 10, exposure to K-252a reduced whole-cell capacitance to 56% of control,_I_A amplitude to 41% of control,_I_D amplitude to 61% of control, and_I_K amplitude to 37% of control, while reducing_I_A density to 51% of control, not affecting_I_D density, and reducing_I_K density to 45% of control. In parallel cultures, exposure to K-252b did not affect total cell capacitance or development of potassium currents.

Fig. 10.

Effects of growth in the presence of the broad spectrum kinase inhibitor K-252a and its PKC-preferring variant K-252b on total cell capacitance and potassium current development. Exposure to K-252a affected membrane area, the amplitudes of_I_A,I_D, and_I_K, and densities of_I_A and I_K. In contrast, exposure to K252b did not affect membrane area or development of any of the potassium currents. Numbers of cells: 21_control, 14 K252a, and 9_K252b.

DISCUSSION

Regulation of electrogenesis

A major implication of these experiments is that growth of particular neuronal regions may be driving targeted insertion of specific ion channels. Thus, whereas some channels may be uniformly distributed over the neuronal surface, membrane expansion may also result in selective insertion of particular channels to create a mosaic of channel types over the neuronal surface.

For developing hippocampal neurons, PI 3-kinases may be critical elements of signaling pathways regulating both A-type potassium channel synthesis and fusion of channel-bearing vesicles into regions of expanding membrane. The late embryonic and early postnatal period examined here (corresponding to the first 7–10 d in culture) is characterized by the initial preferential development of_I_A (Ficker and Heinemann, 1992; Wu and Barish, 1992; Spigelman et al., 1992), and this process was disrupted by exposure of neurons growing in contact with astroglial cells to inhibitors of PI 3-kinases.

Further, dendritic growth may occur by insertion of membrane specifically enriched in A-type potassium channels. Localization of both _I_A (Spigelman et al., 1992; Hoffman et al., 1997) and Kv4.2/3 immunoreactivity (Sheng et al., 1992; Maletic-Savatic et al., 1995b; Tsaur et al., 1997; this report) to somata and dendrites suggests the presence of a population of targeted vesicles bearing A-type potassium channels. These vesicles may be the Kv4.2/3-immunoreactive punctata illustrated (Figs. 7, 8), because their density was reduced by exposure to LY294002, and they were similar in appearance to the mobile tubulovesicular transport vesicles recently described by Nakata et al. (1998). However, we have not yet compared the distributions of Kv4.2/3-immunoreactive structures to markers of compartments of the secretory pathway (Krijnse-Locker et al., 1995), or determined if LY294002 perturbs generation of all transport vesicles, the presence of Kv4.2/3 immunoreactivity on transport vesicles, or both.

Unlike observations on _I_A, changes in_I_D and _I_K amplitudes after inhibition of PI 3-kinases were in proportion to reductions in membrane area (compare Figs. 5A1,2,6A1,2). This suggests either (1) that minimal synthesis of the subunits comprising these channels was occurring during this period and that insertion was drawing on a preexisting subunit pool, or (2) that subunit synthesis was minimally affected by kinase inhibition. Regardless, these data also suggest regulation of channel insertion by PI 3-kinases.

Role of PI 3-kinases

How valid is our interpretation implicating PI 3-kinases in regulation of development of excitability?

First, the specificity of the inhibitors used suggests involvement of PI 3-kinases. We used unrelated membrane-permeant inhibitors of PI 3-kinases, either LY294002 or wortmannin. LY294002 was effective at the micromolar concentration for which it is selective for PI 3-kinases (Vlahos et al., 1994) over PI 4-kinases (Vlahos et al., 1994) or myosin light chain kinase (Yano et al., 1995). Unlike wortmannin, LY294002 is stable when added to cultures (Vlahos et al., 1994). Wortmannin at nanomolar concentrations is selective for PI 3-kinases (Shepherd et al., 1996), but at higher (micromolar) concentrations affects other kinases, including PI 4-kinases (Nakanishi et al., 1995) and myosin light chain kinase (Nakanishi et al., 1992). Wortmannin was used at micromolar concentrations, which appears inconsistent with actions restricted to PI 3-kinases. However, wortmannin is notoriously unstable, and in serum-containing cultures loses effectiveness after ∼5 hr (Kimura et al., 1994). Because wortmannin was added to cultures at intervals of 8 and 16 hr, its concentration was almost certainly below its nominal value. Therefore, although we do not exclude the possibility that wortmannin was affecting other targets, we suggest that a major action of wortmannin was on PI 3-kinases.

Second, because the PI 3-kinases are a family of related kinases (Zvelebil et al., 1996), particular PI 3-kinases might influence hippocampal neuron development at different sites (Ward et al., 1996). PI 3-kinases appear to serve two major overlapping classes of functions. Some PI 3-kinases are activated as part of the signaling cascade initiated by protein tyrosine kinases and may regulate additional kinases potentially linked to control of transcription factor activity (Kapeller and Cantley, 1994) as well as to control of intracellular membrane trafficking (De Camilli et al., 1996; Shepherd et al., 1996). Other PI 3-kinases may directly regulate intracellular membrane trafficking (De Camilli et al., 1996; Shepherd et al., 1996).

Although no other studies have directly addressed involvement of PI 3-kinases in the development of excitability, in studies of PC12 cells, neurite growth was induced by introduction of a constitutively active PI 3-kinase and inhibited by wortmannin (Kimura et al., 1994; Kobayashi et al., 1997). Other studies in neurons have examined PI 3-kinases in relation to regulation of apoptosis (Nomomura et al., 1996; D’Mello et al., 1997; Miller et al., 1997).

Relation to the association of _I_Adevelopment with astroglial contact

The similarity of the results obtained with inhibitors of PI 3-kinases to our previous observations of the effects of astroglial contact (Wu and Barish, 1994), control of _I_Aamplitude and density in association with changes in membrane area, suggests that PI 3-kinases may be elements of intracellular signaling pathways in neurons whose activation is linked to astroglial contact. In this model, reception of signals originating in astroglial cells would activate tyrosine kinases (possibly receptor tyrosine kinases), and subsequent activation of PI 3-kinases could regulate_I_A development. Future work will be directed toward identification of the neuronal receptor(s) responding to astroglial contact and their linkages to particular PI 3-kinases.

Role of myosin light chain kinase

Our observations suggest involvement of myosin and myosin light chain kinase in regulation of vesicle populations available for exocytosis, because exposure to ML-9 reduced membrane area and potassium current amplitudes and the overall luminance of Kv4.2/3 immunoreactivity. Significantly, Kv4.2/3 immunoreactivity showed greater restriction to perinuclear portions than was evident in control neurons or in neurons exposed to the CaMKII inhibitor KN-62, suggesting inhibition of peripheral migration of Kv4.2/3 immunoreactivity. This process was not totally arrested, perhaps because cells possess multiple vesicle transport systems (Fath and Burgess, 1994). Nevertheless, our interpretation is consistent with other analyses of myosin functions (Mermall et al., 1998) because: (1) the subcellular distributions of myosins and their associations with vesicles suggest a transport function in somata (Mermall et al., 1998), and (2) functional analyses of myosins suggest involvement in vesicle transport and exocytosis (Ohara-Imaizumi et al., 1992; Kumakura et al., 1994; Mermall et al., 1994; Mochida et al., 1994; Rao et al., 1997).

Role of calcium–calmodulin-dependent protein kinase II

Our observations also suggest that CaMKII regulates fusion of transport vesicles with the plasmalemma at a site close to the exocytotic step, because growth in the presence of a CaMKII inhibitor reduced membrane area and potassium current amplitudes proportionately without substantially affecting the intensity or distribution of Kv4.2/3 immunoreactivity. This model is consistent with recent observations of chronic CaMKII-sensitive membrane cycling at nonsynaptic as well as synaptic sites on developing hippocampal neurons (Matteoli et al., 1992; Maletic-Savatic et al., 1995a, 1996).

Other studies have also reported a relationship between CaMKII activity and neuronal growth, in particular with neurite extension and branching, and growth cone motility (Cabell and Audesirk, 1993; Goshima et al., 1993; Williams et al., 1995; Audesirk et al., 1997).

Studies of neurotransmitter release indicate that CaMKII may affect exocytosis by regulating vesicle mobility and availability for docking and eventual membrane fusion (Llinás et al., 1985; Greengard et al., 1993; Ceccaldi et al., 1995; Nielander et al., 1995;Maletic-Savatic et al., 1995a, 1996). Similar mechanisms may be involved in neuronal growth regulation.

Role of protein kinase C

Growth in the presence of PKC inhibitors did not affect membrane area (measured electrophysiologically) or potassium current development, an observation consistent with our notion that membrane expansion and potassium channel insertion are linked. This insensitivity to PKC inhibitors was unexpected because PKC regulates a number of processes involving vesicle fusion (Strong et al., 1987;Finch and Jackson, 1990; Parfitt and Madison, 1993; Corey et al., 1994;Billiard et al., 1997). However, in a broad way our observations are consistent with studies indicating that inhibition of PKC with calphostin C reduced only axon branching, but not dendrite number, branching, or length (Cabell and Audesirk, 1993; Audesirk et al., 1997) because we believe A-type potassium channels incorporating Kv4.2/3 subunits to be restricted to somatic and dendritic membrane.

Footnotes

This work was supported by National Institutes of Health National Institute of Neurological Diseases and Stroke Grant R01 NS23857. We thank Arlene Y. Chiu and Charles E. Niesen for their helpful comments on this manuscript, Dianne M. Barry and Jeanne M. Nerbonne for their generous gifts of antibodies, and M. Jill Flanagan for her assistance with manuscript preparation.
Correspondence should be addressed to Dr. Michael E. Barish, Division of Neurosciences, Beckman Research Institute of the City of Hope, Duarte, CA 91010.